In light of all the evidence relating extracellular matrix alterations and cancer development, the present work aimed to elucidate the possible role of HPSE1, heparan sulfate (HS) and Syn-1 in breast cancer cell resistance to trastuzumab. Here, SYN1 is linked to breast cancer.